GIMV (EBR:GIMB) Gimv participates in $105 million financing of Mediar Therapeutics alongside fellow leading global life sciences investors to develop first-in-class fibrosis therapies
Directive transparence : information réglementée INVESTMENT
15/03/2023 07:28
29/02/2024 07:45
27/02/2024 07:45
16/01/2024 07:30
19/12/2023 07:30
08/12/2023 12:00
30/11/2023 21:24
23/11/2023 06:58
20/09/2023 07:30
18/09/2023 07:29
11/09/2023 07:30